Even before the COVID-19 pandemic, the point-of-care testing industry was investing millions of pounds to develop rapid tests to tell us the cause of respiratory infections. The pandemic has accelerated this process. In an ...
Nov 18, 2020
0
1
For patients with knee osteoarthritis (KOA), methotrexate added to usual medication is associated with a significant reduction in pain and improvement in stiffness and function at six months, according to a study published ...
Jul 31, 2024
0
0
A large study of older Australians has found more would exercise—and exercise better—if classes were subsidized.
Aug 5, 2024
0
16
Sweden's acclaimed research on uterine transplants has taken a new step forward: into the field of health economics. Now, for the first time, there is a scientifically based estimate of how much implementing the treatment ...
Apr 7, 2021
0
1
A study by health economists at the University of York has, for the first time, produced an estimate of the impact on other NHS patients of new and more costly drugs and other treatments.
Jan 24, 2013
0
0
(HealthDay)—The use of concurrent carbogen and nicotinamide (CON) with radiation therapy is feasible for patients with muscle invasive bladder cancer (MIBC) in the Australian setting, according to a study published online ...
Jul 8, 2021
0
1
Genomic screening to identify hemochromatosis—a disorder that causes iron levels in the body to rise to dangerous levels—encourages people with the condition to seek treatment and ongoing management, a Geisinger has study ...
Oct 26, 2023
0
0
The body that appraises the clinical and cost effectiveness of new drugs in England would do well to take a leaf out of its sister organisations' books in Wales and Scotland, says an editorial in the Drug and Therapeutics ...
Dec 14, 2013
0
0
Nasal-administered naloxone is more cost-effective and could help reduce the number of opioid-related fatalities compared to the current publicly funded intermuscular version, a new study has found. The study, "An economic ...
Apr 8, 2024
0
0
From an economic perspective, first-line prostate-specific antigen (PSA) testing is favored over biparametric magnetic resonance imaging (bpMRI) for prostate cancer screening, mainly due to false-positive results and overdiagnosis, ...
Jun 4, 2024
0
0
